The ALS Therapy Alliance - Researching a Cure
Follow our journey as we blog about the leading-edge research the ALS Therapy Alliance and its partners is conducting. Meet our campaign spokespeople and learn more about how their families are living with the disease and remaining hopeful that a cure will be found. We welcome your comments and feedback!
The Northeast ALS Consortium (NEALS) will be hosting an interactive Webinar about - Contributing to an ALS Sample Repository to Help Forward ALS Research.
DATE: Wednesday, April 6, 2011
TIME: 2:00 p.m. - 3:00 p.m EST
WHO: Robert Bowser, PhD, Merit Cudkowicz, MD, MSc
and Carol Milligan, PhD
HOW TO JOIN: Space is limited. To reserve your Webinar seat now, click here...> After registering, you will receive a confirmation email containing information about joining the Webinar.
DETAILS: Expert panelists will discuss and answer questions about:
- The importance of biosamples to ALS research
- How biosamples are used to further research
- Why finding a biomarker is so important to ALS
- Ways to donate samples and how the donation is collected
This free Webinar is for people with ALS, their families and caregivers. Please feel free to forward announcement to those interested.
NEALS hosts regular Webinars on important clinical and clinical research topics for people with ALS. For a list of other upcoming NEALS Webinars please click here...>
Related Post
- WEBINAR: The Ceftriaxone Study - February 9th at 2:00pm EST The Northeast Consortium (NEALS) announces that Dr. Merit Cudkowicz, Principal Investigator for the Ceftriaxone study, will hold an informational Webi...
- WEBCAST: Antisense Drug Clinical Study in Patients with Familial ALS Due to Mutations in SOD1 The Northeast ALS Consortium (NEALS) will be hosting an interactive webcast about ALS clinical trials, familial ALS, and the ISIS-SOD1RX clinical stud...
- Request for Proposals: Clinical development of novel, high-potential treatments for people with ALS The Neurology Clinical Trial Unit (NCTU) at Mass General is offering a great funding opportunity for investigators and companies interested in conduct...

